Home [sandbox] K4D COVID-19 Resource Hub

[sandbox] K4D COVID-19 Resource Hub

Sort by: Date tagged Date published

1
2
3
4
…
48

51 - 75 of 1176

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report

https://api.zotero.org/groups/2494380/items/U4CZTRXT?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

https://api.zotero.org/groups/2494380/items/92N23DYZ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

https://api.zotero.org/groups/2494380/items/MRPRFHAJ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

https://api.zotero.org/groups/2494380/items/87VE3UPH?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021
Genetic mechanisms of critical illness in Covid-19

https://api.zotero.org/groups/2494380/items/X2QSHGRH?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Rapid triage for COVID-19 using routine clinical data for patients attending hospital: development and prospective validation of an artificial intelligence screening test

https://api.zotero.org/groups/2494380/items/ZQRQK8JB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Global Mobility and the Threat of Pandemics: Evidence from Three Centuries

https://api.zotero.org/groups/2494380/items/CZKBXAL9?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study

https://api.zotero.org/groups/2494380/items/T7R5USDY?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

https://api.zotero.org/groups/2494380/items/R8SKMFHB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

https://api.zotero.org/groups/2494380/items/VBDBJIXY?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection

https://api.zotero.org/groups/2494380/items/HM4BKSP3?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

https://api.zotero.org/groups/2494380/items/Q5AD6SRX?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

https://api.zotero.org/groups/2494380/items/I7DNTRFA?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

https://api.zotero.org/groups/2494380/items/TBZPTNDS?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials

https://api.zotero.org/groups/2494380/items/LMLWLHY6?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Nigeria: Where Covid-19 Has Left Nigeria's Health System

https://api.zotero.org/groups/2494380/items/4Q3DCFMB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Any Delay in Ending COVID Could Spur a Different Pandemic

https://api.zotero.org/groups/2494380/items/V7JVBWHH?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Facing up to long COVID

https://api.zotero.org/groups/2494380/items/DIT8BH3Y?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Coronavirus Vaccine Update With Anthony Fauci – December 11, 2020

https://api.zotero.org/groups/2494380/items/29NUQ987?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Reimagining India's health system: a Lancet Citizens’ Commission

https://api.zotero.org/groups/2494380/items/F67YVBQF?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
The COVID-19 vaccines rush: participatory community engagement matters more than ever

https://api.zotero.org/groups/2494380/items/WY7E34NB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
Restricting Mobility Will Not Stop the Next Pandemic

https://api.zotero.org/groups/2494380/items/DU49ES98?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
A Tale Of Two Crises And The Solutions That Bind Them: Wild Polio And COVID-19

https://api.zotero.org/groups/2494380/items/Y6J22945?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
A step backwards in the fight against global vaccine inequities

https://api.zotero.org/groups/2494380/items/Y3CFHSKA?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020
From governance to community surveillance: Assam’s 360 degree COVID-19 response

https://api.zotero.org/groups/2494380/items/UTAMZUH6?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

1
2
3
4
…
48

51 - 75 of 1176